Related Experiment Video
Updated: Jul 5, 2026

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR
Published on: February 5, 2018
The NMD mRNA surveillance pathway downregulates aberrant E-cadherin transcripts in gastric cancer cells and in CDH1
1Cancer Genetics Group, Institute of Molecular Pathology and Immunology, University of Porto (IPATIMUP), Porto, Portugal.
Abstract:
Germline mutations in the gene encoding the tumour suppressor E-cadherin (CDH1) are the underlying genetic defect responsible for hereditary diffuse gastric cancer (HDGC). A remarkably high percentage ( approximately 80%) of CDH1 mutations in HDGC patients and carriers generate premature termination codons (PTCs). Here, we examined whether CDH1 transcripts harbouring PTCs are downregulated by nonsense-mediated decay (NMD), an RNA surveillance pathway that degrades PTC-bearing transcripts. Using an allele-specific expression (ASE) assay to differentiate between mutated and wild-type CDH1 alleles, we found that PTC-bearing CDH1 mRNAs are strongly downregulated in normal gastric tissue from several CDH1 mutation carriers. We show that NMD is responsible for this robust downregulation, as CDH1 transcripts harbouring PTCs in the KATO-III gastric tumour cell line were upregulated in response to protein synthesis inhibitors or depletion of the NMD factors UPF1 and eIF4AIII. Analysis of HDGC patients harbouring CDH1 alleles with PTCs at a wide variety of different positions indicates an association of their predicted ability to induce NMD and an earlier age of onset of gastric cancer. This suggests that NMD may be detrimental for HDGC patients and therefore NMD is a potentially useful therapeutic target for CDH1 mutation carriers.
Insights
Nonsense-mediated decay (NMD) downregulates tumor suppressor E-cadherin (CDH1) transcripts with premature termination codons (PTCs) in hereditary diffuse gastric cancer (HDGC). This NMD activity may worsen patient outcomes, suggesting NMD as a therapeutic target.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Research
Background:
- Germline mutations in the E-cadherin (CDH1) gene cause hereditary diffuse gastric cancer (HDGC).
- Approximately 80% of CDH1 mutations in HDGC patients lead to premature termination codons (PTCs).
Purpose of the Study:
- To investigate if nonsense-mediated decay (NMD) downregulates CDH1 transcripts containing PTCs.
- To explore the role of NMD in HDGC pathogenesis and its potential as a therapeutic target.
Main Methods:
- Utilized an allele-specific expression (ASE) assay to distinguish between mutated and wild-type CDH1 alleles.
- Examined CDH1 transcript levels in normal gastric tissue from HDGC carriers and in the KATO-III gastric tumor cell line.
- Assessed the effect of protein synthesis inhibitors and depletion of NMD factors (UPF1, eIF4AIII) on CDH1 transcript levels.
Main Results:
- PTC-bearing CDH1 mRNAs were significantly downregulated in normal gastric tissue from HDGC mutation carriers.
- NMD was confirmed as the mechanism responsible for CDH1 transcript downregulation.
- CDH1 transcripts with PTCs were upregulated upon NMD inhibition in a gastric tumor cell line.
- A correlation was found between the predicted NMD-inducing ability of CDH1 PTCs and an earlier age of gastric cancer onset in HDGC patients.
Conclusions:
- Nonsense-mediated decay (NMD) actively degrades CDH1 transcripts with premature termination codons (PTCs).
- NMD's role in downregulating CDH1 may contribute to earlier onset of gastric cancer in HDGC patients.
- NMD represents a potential therapeutic target for individuals with CDH1 mutations and HDGC.
Related Concept Videos
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Abnormal Proliferation
Nuclear Export of mRNA
Structure of Cadherins
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...